About China Kanghui (NYSE:KH)
China Kanghui Holdings is a holding company and conducts all of its business through its two wholly owned subsidiaries in China, Changzhou Kanghui Medical Innovation Co., Ltd. (Changzhou Kanghui) and Beijing Libeier. The Company is a domestic developer, manufacturer and marketer of orthopedic implants in People's Republic of China. The Company's orthopedic implant brands are Kanghui and Libeier. It sells two lines of orthopedic implant products, trauma and spine. Its major trauma products, used in the surgical treatment of bone fractures, include a range of nails, plates and screws. Its major spine products, used in the surgical treatment of spine disorders, include screws, meshes, interbody cages and fixation systems. On July 31, 2008, we acquired 100% of the equity interests of Beijing Libeier. On July 31, 2009, the Company established Shanghai Zhikang Medical Devices Co., Ltd. (Shanghai Zhikang), which is wholly owned by Changzhou Kanghui.
Industry, Sector and Symbol
Industry Medical Devices & Implants
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
China Kanghui (NYSE:KH) Frequently Asked Questions
What is China Kanghui's stock symbol?
China Kanghui trades on the New York Stock Exchange (NYSE) under the ticker symbol "KH."
Who are some of China Kanghui's key competitors?
Some companies that are related to China Kanghui include Roche (ROG), Sanofi (SAN), Bayer (BAYN), CSL (CSL), GlaxoSmithKline (GSK), AstraZeneca (AZN), Covidien (COV), Beximco Pharmaceuticals (BXP), Shire (SHP), Essilor International (EI), C R Bard (BCR), Medivation (MDVN), Ramsay Health Care (RHC), CareFusion (CFN), AEGON (AGN), Bioverativ (BIVV), Cochlear (COH) and Salix Pharmaceuticals (SLXP).
Has China Kanghui been receiving favorable news coverage?
News headlines about KH stock have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. China Kanghui earned a daily sentiment score of 0.11 on Accern's scale. They also gave news stories about the company an impact score of 46.34 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near future.
How do I buy shares of China Kanghui?
Shares of KH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact China Kanghui?
China Kanghui's mailing address is No. 11 Changjiang North Road, Xinbei District, CHANGZHOU, JNG 213022, China. The company can be reached via phone at +86-519-85195556.
MarketBeat Community Rating for China Kanghui (KH)MarketBeat's community ratings are surveys of what our community members think about China Kanghui and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
China Kanghui (NYSE:KH) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
China Kanghui (NYSE:KH) Earnings History and Estimates Chart
China Kanghui (NYSE KH) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
China Kanghui (NYSE:KH) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for China Kanghui (NYSE:KH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for China Kanghui (NYSE KH)
No insider trades for this company have been tracked by MarketBeat.com
China Kanghui (NYSE KH) News Headlines
China Kanghui (NYSE:KH) SEC Filings
This page is loading this company's SEC Filings. Please wait...
China Kanghui (NYSE:KH) Income Statement, Balance Sheet and Cash Flow Statement
China Kanghui (NYSE KH) Stock Chart for Monday, March, 19, 2018